The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2016
Filed:
Nov. 23, 2012
Applicant:
Bayer Intellectual Property Gmbh, Monheim, DE;
Inventors:
Hans-Georg Schwarz, Dorsten, DE;
Axel Trautwein, Düsseldorf, DE;
Lothar Willms, Hofheim, DE;
Maike Hink, Markgröningen, DE;
Peter Lümmen, Idstein, DE;
Ulrich Görgens, Ratingen, DE;
Pierre-Yves Coqueron, Lyons, FR;
Achim Harder, Köln, DE;
Claudia Welz, Düsseldorf, DE;
Joerg Nico Greul, Leverkusen, DE;
Assignee:
BAYER INTELLECTUAL PROPERTY GMBH, Monheim am Rhein, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 211/72 (2006.01); C07D 417/12 (2006.01); A61K 31/166 (2006.01); A61K 31/18 (2006.01); A61K 31/341 (2006.01); A61K 31/381 (2006.01); A61K 31/425 (2006.01); A61K 31/4402 (2006.01); A61K 31/4406 (2006.01); A61K 31/443 (2006.01); A61K 31/4436 (2006.01); A61K 31/4439 (2006.01); C07C 233/73 (2006.01); C07D 213/82 (2006.01); C07D 275/03 (2006.01); C07D 307/68 (2006.01); C07D 333/24 (2006.01); C07D 333/38 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); A61K 31/166 (2013.01); A61K 31/18 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/425 (2013.01); A61K 31/4402 (2013.01); A61K 31/443 (2013.01); A61K 31/4406 (2013.01); A61K 31/4436 (2013.01); A61K 31/4439 (2013.01); C07C 233/73 (2013.01); C07D 213/82 (2013.01); C07D 275/03 (2013.01); C07D 307/68 (2013.01); C07D 333/24 (2013.01); C07D 333/38 (2013.01); C07D 409/12 (2013.01);
Abstract
The present application relates to known and novel aryl- and hetarylcarboxamides of the formula (I) and to their use as medicaments for controlling endoparasites in animals or humans, and also to parasiticidal compositions, in particular endoparasites, comprising aryl- and hetarylcyclylcarboxamides.